Cargando…
The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor
Vitamin D has been shown to have antiviral activity in a number of different systems. However, few studies have investigated whether the antiviral activity is exerted through the vitamin D receptor (VDR). In this study, we investigated whether the antiviral activity of a vitamin D receptor agonist (...
Autores principales: | Jaratsittisin, Janejira, Sornjai, Wannapa, Chailangkarn, Thanathom, Jongkaewwattana, Anan, Smith, Duncan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581485/ https://www.ncbi.nlm.nih.gov/pubmed/37847693 http://dx.doi.org/10.1371/journal.pone.0293010 |
Ejemplares similares
-
Activity of vitamin D receptor agonists against dengue virus
por: Jaratsittisin, Janejira, et al.
Publicado: (2020) -
Strain Variation Can Significantly Modulate the miRNA Response to Zika Virus Infection
por: Ramphan, Suwipa, et al.
Publicado: (2023) -
Analysis of Zika virus neutralizing antibodies in normal healthy Thais
por: Sornjai, Wannapa, et al.
Publicado: (2018) -
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer
por: Evans, T R J, et al.
Publicado: (2002) -
A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.
por: Gulliford, T., et al.
Publicado: (1998)